[The artery and the myocardium, two post-infarction targets]

Presse Med. 2004 Sep 25;33(16):1135-6. doi: 10.1016/s0755-4982(04)98869-0.

[Article in French]

Authors

J-F Aupetit¹, J-P Senac, R Latini, F Zannad

Affiliation

¹ Centre Hospitalier Saint-Joseph, Saint-Luc, Lyon, France.

PMID: 15523278
DOI: 10.1016/s0755-4982(04)98869-0

No abstract available

Publication types

Review

MeSH terms

Adrenergic beta-Antagonists / therapeutic use
Angiotensin-Converting Enzyme Inhibitors / therapeutic use
Humans
Mineralocorticoid Receptor Antagonists / therapeutic use
Myocardial Infarction / complications*
Myocardial Infarction / drug therapy*
Myocardial Ischemia / etiology*
Myocardial Ischemia / pathology
Risk Factors
Ventricular Dysfunction, Left

Substances

Adrenergic beta-Antagonists
Angiotensin-Converting Enzyme Inhibitors
Mineralocorticoid Receptor Antagonists